89bio Alternatives & Competitors
12 companies similar to 89bio — Developing and commercializing innovative therapies for the treatment of liver a...
Companies similar to 89bio
HighTide Therapeutics
East Meets West—The Quest for Cure
Shenzhen, China
Madrigal Pharmaceuticals
Madrigal is focused on delivering novel therapeutics for MASH, a serious liver disease.
Conshohocken, United Stat...
Cirius Therapeutics
Pioneering the future of liver and metabolic disease treatment with innovative insulin sen...
CymaBay Therapeutics
Dedicated to improving the lives of patients with liver diseases
Newark, United States
Track all 89bio competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Theratechnologies Inc.
Health innovation that matters | #HIV #NASH #Oncology
Montreal, Canada
Soleno Therapeutics, Inc.
Inspired by patients and families around the world, we are advancing much needed therapies...
Redwood City, United Stat...
PaxMedica, Inc.
Empowering Possibilities, Transforming Lives: PaxMedica's Journey in Neurodevelopmental So...
Tarrytown, United States
Angion
Angion is committed to transforming the treatment paradigm for patients suffering from fib...
United States
Ocera Therapeutics
Dedicated to Innovation in Liver Disease Treatment, Pioneering Life-Saving Therapeutics fo...
Spruce Biosciences
Advancing Treatments for Congenital Adrenal Hyperplasia and Other Rare Endocrine Disorders
South San Francisco, Unit...
Eidos Therapeutics
Pioneering genetically targeted therapies to swiftly translate breakthrough science into l...
About 89bio
89bio 89bio is a clinical-stage biopharmaceutical company with a focus on developing and commercializing innovative therapies for the treatment of liver and cardio-metabolic diseases. Their lead product candidate, BIO89-100, is an engineered glycoPEGylated analog of FGF21 designed for the treatment of nonalcoholic stea...
Biopharmaceutical Company, Clinical-stage, FGF21 Analog, NASH Treatment, SHTG Treatment, Liver Diseases, Cardio-metabolic Diseases, Innovative Therapies, Phase 2 Trial, Patient-centric, Ethical Standards, Scientific Advancement, San Francisco, Herzliya, Israel
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches 89bio and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at 89bio on 9 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
